25G-NBOMe, also known as NBOMe-2C-G, is a derivative of the phenethylamine hallucinogen 2C-G, which acts as a highly potent agonist for the human 5-HT2A receptor.
Toxicity and harm potential
Neurotoxic and cardiotoxic actions
Emergency treatment
Society and culture Legal status Canada 25G-NBOMe is a controlled substance in Canada under phenethylamine blanket-ban language.
Sweden The Riksdag added 25G-NBOMe to Narcotic Drugs Punishments Act under swedish schedule I ("substances, plant materials and fungi which normally do not have medical use") as of January 16, 2015, published by Medical Products Agency (MPA) in regulation LVFS 2014:11 listed as 25G-NBOMe, and 2-(2,5-dimetoxi-3,4-dimetylfenyl)-N-(2-metoxibensyl)etanamin.
United Kingdom
See also 25-NB
Notes
References